Trials / Completed
CompletedNCT06236165
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Investigating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetylcysteine | Patients will receive oral N-acetylcysteine 600 mg twice daily in addition to supportive treatment, for 3 months. |
Timeline
- Start date
- 2024-02-14
- Primary completion
- 2025-01-22
- Completion
- 2025-01-22
- First posted
- 2024-02-01
- Last updated
- 2025-07-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06236165. Inclusion in this directory is not an endorsement.